Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | CA12 | O43570 | 5/20 | 0.60 |
| ▸ | CA6 | P23280 | 5/20 | 0.60 |
| ▸ | CA7 | P43166 | 5/20 | 0.60 |
| ▸ | CA9 | Q16790 | 5/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.60 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.60 |
| ▸ | CA2 | P00918 | 4/20 | 0.60 |
| ▸ | CA4 | P22748 | 4/20 | 0.60 |
| ▸ | CA5A | P35218 | 4/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | CASP2 | P42575 | 2/20 | 0.60 |
| ▸ | F13A1 | P00488 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | THPO | P40225 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7991030 | 0.97 | TDP1 (0.58) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL19179134 | 0.95 | TDP1 (0.58) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL12520087 | 0.95 | TDP1 (0.58) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL29225286 | 0.95 | ALOX15 (0.59) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL12827888 | 0.95 | TDP1 (0.56) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL19179347 | 0.93 | CASP2 (0.59) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL5360673 | 0.92 | CA12 (0.62) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL19181585 | 0.92 | CA12 (0.57) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL13336449 | 0.92 | CA12 (0.65) | TDP1CA12CA6CA7CA9 | |
| SCHEMBL831497 | 0.92 | CA12 (0.57) | TDP1CA12CA6CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12448542-B2 | Slurry composition for polishing organic film | KCTECH CO., LTD. (KR) | 2025-10-21 | — | — | US | claimed |
| US-20250145859-A1 | SLURRY COMPOSITION FOR CHEMICAL MECHANICAL POLISHING | KCTECH CO., LTD. (KR) | 2025-05-08 | — | — | US | claimed |
| US-20230033789-A1 | SLURRY COMPOSITION FOR POLISHING ORGANIC FILM | KCTECH CO., LTD. (KR) | 2023-02-02 | — | — | US | claimed |
| CN-111492024-B | Polishing slurry composition for STI process | 斯科技股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| US-11384255-B2 | Polishing slurry composition for STI process | KCTECH CO., LTD. (KR) | 2022-07-12 | — | — | US | claimed |
| US-20220177727-A1 | POLISHING SLURRY COMPOSITION FOR STI PROCESS | KCTECH CO., LTD. (KR) | 2022-06-09 | — | — | US | claimed |
| WO-2021125919-A1 | SLURRY COMPOSITION FOR POLISHING ORGANIC FILM | 주식회사 케이씨텍 | 2021-06-24 | — | — | WO | claimed |
| US-20210163785-A1 | POLISHING SLURRY COMPOSITION FOR STI PROCESS | KCTECH CO., LTD. (KR) | 2021-06-03 | — | — | US | claimed |
| US-20210079262-A1 | POLISHING SLURRY COMPOSITION FOR STI PROCESS | KCTECH CO., LTD. (KR) | 2021-03-18 | — | — | US | claimed |
| WO-2020130256-A1 | POLISHING SLURRY COMPOSITION FOR STI PROCESS | 주식회사 케이씨텍 | 2020-06-25 | — | — | WO | claimed |
| EP-2151463-A2 | Alkylated aminopropylated methylene-di-(cyclohexylamine) and uses thereof | Air Products and Chemicals, Inc. (US) | 2010-02-10 | — | — | EP | claimed |
| EP-1956034-B1 | Alkylated polyalkyleneamines and uses thereof | AIR PROD & CHEM (US) | 2009-09-30 | — | — | EP | claimed |
| US-20090163676-A1 | Benzylated Polyalkylene Polyamines And Uses Thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-06-25 | — | — | US | claimed |
| US-20090029175-A1 | Alkylated Polyalkylene Polyamines And Uses Thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-01-29 | — | — | US | claimed |
| US-20090030125-A1 | Benzylated Aminopropylated Ethylenediamines And Uses Thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-01-29 | — | — | US | claimed |
| US-20090030159-A1 | Alkylated Aminopropylated Ethylenediamines And Uses Thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-01-29 | — | — | US | claimed |
| US-20090023846-A1 | Benzylated Polyalkylene Polyamines And Uses Thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-01-22 | — | — | US | claimed |
| US-20090018278-A1 | Alkylated Aminopropylated Methylene-Di-(Cyclohexylamine) And Uses Thereof | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-01-15 | — | — | US | claimed |
| EP-1956034-A1 | Alkylated polyalkyleneamines and uses thereof | Air Products and Chemicals, Inc. (US) | 2008-08-13 | — | — | EP | claimed |
| US-20080188591-A1 | Alkylated Polyalkyleneamines and Uses Thereof | EVONIK OPERATIONS GMBH (DE) | 2008-08-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030159-A1 | Alkylated Aminopropylated Ethylenediamines And Uses Thereof | CYP19A1, ESR1, PNMT | TDP1 700/4885CA12 3797/4885CA6 4255/4885 |
| US-20090018278-A1 | Alkylated Aminopropylated Methylene-Di-(Cyclohexylamine) And Uses Thereof | ACMSD, PNMT, ALKBH5 | TDP1 2508/4885CA12 3429/4885CA6 2514/4885 |
| US-20090030125-A1 | Benzylated Aminopropylated Ethylenediamines And Uses Thereof | AADAT, PNMT, CYP19A1 | TDP1 737/4885CA12 3633/4885CA6 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.